In the life sciences and legal sectors, “legalese” and “medicalese” often act as barriers to understanding. Complex terminology, dense syntax, and archaic phrasing can make critical documents inaccessible to the very people they are meant to protect: patients, trial participants, and the public. However, the global shift toward transparency—driven by regulations like EU CTR 536/2014—has…